Advanced search
Publication Cover
Journal of Medical Economics Volume 13, 2010 - Issue 3
Submit an article Journal homepage
1,114
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Cost effectiveness of deferasirox compared to desferrioxamine in the treatment of iron overload in lower-risk, transfusion-dependent myelodysplastic syndrome patients

K. Tolley Tolley Health Economics Ltd., Buxton, Derbyshire, UKCorrespondence[email protected]
,
N. Oliver Novartis Pharmaceuticals UK Ltd., Frimley, Surrey, UK
,
E. Miranda Novartis Pharmaceuticals UK Ltd., Frimley, Surrey, UK
,
K. Migliaccio-Walle United BioSource Corporation, Lexington, Massachusetts, USA
,
D. Bozkaya United BioSource Corporation, Lexington, Massachusetts, USA
&
Q. Li United BioSource Corporation, Lexington, Massachusetts, USA
Pages 559-570 | Accepted 13 Aug 2010, Published online: 02 Sep 2010

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Natalia Olchanski, Yue Zhong, Joshua T. Cohen, Cayla Saret, Mohan Bala & Peter J. Neumann. (2015) The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology. Expert Review of Pharmacoeconomics & Outcomes Research 15:6, pages 931-940.
Read now
Junya Kanda, Hiroshi Kawabata & Nelson J Chao. (2011) Iron overload and allogeneic hematopoietic stem-cell transplantation. Expert Review of Hematology 4:1, pages 71-80.
Read now

Articles from other publishers (6)

Amer M. Zeidan, Vinod A. Pullarkat & Rami S. Komrokji. (2017) Overcoming barriers to treating iron overload in patients with lower-risk myelodysplastic syndrome. Critical Reviews in Oncology/Hematology 117, pages 57-66.
Crossref
Sita lakshmi Thyagarajan, Giriprasath Ramanathan, Sivakumar Singaravelu, S. Kandhasamy, P.T. Perumal & Uma Tiruchirapalli Sivagnanam. (2017) Microbial Siderophore as MMP inhibitor:An interactive approach on wound healing application. Wound Medicine 16, pages 7-14.
Crossref
Doug CoyleMatthew C. CheungGerald A. Evans. (2014) Opportunity Cost of Funding Drugs for Rare Diseases. Medical Decision Making 34:8, pages 1016-1029.
Crossref
Kiarash Tazmini, Heidi Bakken & Fredrik Schjesvold. (2012) En kvinne i 70-årene med redusert allmenntilstand, dyspné og utbredte smerter. Tidsskrift for Den norske legeforening 132:17, pages 1969-1972.
Crossref
Senthilkumar Durairaj, Stephen Chew, Ann Hyslop, Norene Keenan, Michael J. Groves & Sudhir Tauro. (2011) Predicted costs of iron‐chelators in myelodysplastic syndromes: A 10‐year analysis based on actual prevalence and red cell transfusion rates. American Journal of Hematology 86:5, pages 406-410.
Crossref
Heather A. Leitch. (2011) Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes. Drugs 71:2, pages 155-177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.